These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33899946)

  • 41. Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.
    Guo W; Zhang W; Liu C; Song Y; Bai O
    PLoS One; 2015; 10(6):e0129064. PubMed ID: 26053951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
    Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
    Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
    Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
    Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
    Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
    JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
    Kuo P; Manes RP; Schwam ZG; Judson BL
    Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?
    Teitelbaum JI; Issa K; Barak IR; Ackall FY; Jung SH; Jang DW; Abi Hachem R
    Otolaryngol Head Neck Surg; 2020 Nov; 163(5):986-991. PubMed ID: 32600116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
    Xiao M; Lin J; Xiao T; Lin Y; Ye Y
    Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736.
    Stephens DM; Li H; LeBlanc ML; Puvvada SD; Persky D; Friedberg JW; Smith SM
    J Clin Oncol; 2016 Sep; 34(25):2997-3004. PubMed ID: 27382104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
    Pfreundschuh M; Ho AD; Cavallin-Stahl E; Wolf M; Pettengell R; Vasova I; Belch A; Walewski J; Zinzani PL; Mingrone W; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Corrado C; Scheliga A; Loeffler M; Kuhnt E;
    Lancet Oncol; 2008 May; 9(5):435-44. PubMed ID: 18400558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.
    Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease.
    Proulx GM; Caudra-Garcia I; Ferry J; Harris N; Greco WR; Kaya U; Chan A; Wang CC
    Am J Clin Oncol; 2003 Feb; 26(1):6-11. PubMed ID: 12576916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.
    Li X; Shen W; Cao J; Wang J; Chen F; Wang C; Zou S; Shen B; Zhao R; Li J; Shen Z
    Ann Hematol; 2012 Nov; 91(11):1721-9. PubMed ID: 22733613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
    Haque W; Verma V; Butler EB; Teh BS
    J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL).
    Liu B; Li B; Zhou P; Yue W; Wang T; Wang J; Hu X; Zhang W; Chen J; Chen L; Gao L; He M; Yang J
    Clin Chim Acta; 2018 Jul; 482():191-198. PubMed ID: 29649456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
    Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.
    Meerwein CM; Hüllner M; Braun R; Soyka MB; Morand GB; Holzmann D
    Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2259-2265. PubMed ID: 31098872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.
    Ganti A; Raman A; Shay A; Kuhar HN; Auger SR; Patel T; Kuan EC; Diaz AZ; Batra PS; Tajudeen BA
    Laryngoscope; 2020 Feb; 130(2):275-282. PubMed ID: 31021415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.